IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,201,000 | -43.4% | 166,099 | +1.2% | 4.09% | -39.5% |
| Q3 2016 | $3,890,000 | +92.2% | 164,156 | +133.7% | 6.76% | +82.4% |
| Q2 2016 | $2,024,000 | +1.9% | 70,235 | +13.2% | 3.71% | -28.4% |
| Q1 2016 | $1,987,000 | -9.6% | 62,050 | +20.6% | 5.18% | +55.8% |
| Q4 2015 | $2,199,000 | +63.1% | 51,430 | +34.4% | 3.32% | +10.7% |
| Q3 2015 | $1,348,000 | – | 38,279 | – | 3.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |